0
points
—
0
points
—
The National Institutes of Health Stroke Scale (NIHSS) is the gold standard clinical assessment tool for quantifying the severity of acute ischemic stroke. Developed by the National Institutes of Health in 1989 and refined through subsequent validation studies, the NIHSS provides a systematic, quantitative measure of stroke-related neurological deficit through a 15-item examination that can be completed in approximately 6 to 10 minutes at the bedside. It has become indispensable in modern stroke care, guiding treatment decisions from thrombolysis eligibility to long-term outcome prediction.
The scale evaluates key domains of neurological function: level of consciousness (alertness, orientation questions, command-following), gaze, visual fields, facial palsy, motor strength (arms and legs bilaterally), limb ataxia, sensory function, language, dysarthria (speech clarity), and neglect (extinction and inattention). Each item is scored on a 3- to 5-point ordinal scale, and individual scores are summed to produce a total NIHSS score ranging from 0 (no deficit) to 42 (maximum deficit).
The NIHSS is central to stroke treatment protocols worldwide. In the acute setting, it helps determine eligibility for intravenous thrombolysis (tPA) — typically administered for moderate-to-severe strokes (NIHSS generally 4–25) — and mechanical thrombectomy for large vessel occlusions. Serial NIHSS assessments track clinical response to treatment: a decrease of 4 or more points within 24 hours is generally considered a clinically meaningful improvement. The score also serves as a powerful predictor of long-term outcomes, with higher initial scores correlating with greater disability and mortality at 3 months.
This calculator enables rapid, standardized NIHSS scoring at the bedside or during telemedicine consultations, supporting time-critical treatment decisions in acute stroke care. It categorizes stroke severity to facilitate communication among healthcare providers and guide appropriate resource allocation.
The NIHSS comprises 15 items across 11 domains of neurological function:
Total score range: 0–42. Severity classification: 0 = no stroke symptoms; 1–4 = minor stroke; 5–15 = moderate stroke; 16–20 = moderate-to-severe stroke; 21–42 = severe stroke.
An NIHSS of 0 indicates no measurable neurological deficit. Scores of 1–4 indicate a minor stroke — these patients may not benefit from thrombolysis and often have favorable outcomes. Scores of 5–15 indicate a moderate stroke and typically represent the target population for IV tPA. Scores of 16–20 indicate moderate-to-severe stroke with significant disability. Scores of 21–42 indicate severe stroke with poor prognosis and high rates of mortality or severe disability at 3 months.
Inputs
Results
NIHSS 3 — minor stroke with mild right-sided weakness and facial droop.
Inputs
Results
NIHSS 19 — moderate-severe stroke with dense right hemiplegia and aphasia.
The NIHSS is a 15-item standardized clinical examination that quantifies neurological deficit severity in acute stroke patients, scoring domains including consciousness, motor function, sensory function, language, and neglect on a 0–42 point scale.
A trained examiner can complete the NIHSS in approximately 6–10 minutes. Certification training is available through the American Heart Association and typically takes about one hour.
There is no strict NIHSS cutoff for tPA eligibility, but IV thrombolysis is generally most beneficial for patients with NIHSS scores of 4 or higher within 4.5 hours of symptom onset. Scores above 25 carry higher bleeding risk.
A decrease of 4 or more points is generally considered clinically meaningful improvement. An increase of 4 or more points suggests neurological deterioration requiring urgent evaluation.
Yes. The initial NIHSS score is one of the strongest predictors of 3-month functional outcomes. Higher baseline scores correlate with greater disability, institutionalization, and mortality.
The NIHSS has a left-hemisphere bias (language is weighted more heavily than neglect), may underestimate posterior circulation strokes, and does not assess all neurological functions (e.g., memory, executive function).
While developed for ischemic stroke, the NIHSS is frequently used to quantify deficit severity in hemorrhagic stroke as well. However, it was not originally validated for this population.
The maximum score is 42, representing the most severe neurological deficit across all domains. Scores above 25 generally indicate a very poor prognosis with high mortality.
Yes. The NIHSS has been validated for telemedicine-based stroke assessment, enabling remote neurologists to guide thrombolysis decisions at hospitals without on-site stroke specialists.
Standard protocols reassess NIHSS at 24 hours post-treatment, at discharge, and at 90-day follow-up. More frequent assessments may be performed if neurological deterioration is suspected.
Roboculator Team
The Roboculator Team explains calculations, planning tools, and practical formulas in clear language for real-life situations.
How helpful was this calculator?
Be the first to rate!
